Early Diagnosis of SCD Based on Radiogenomics

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Alzheimer DiseaseSubjective Cognitive DeclineNeuroimagingGene
Interventions
DIAGNOSTIC_TEST

Multiple features extraction

"In the present study, the gold standard of preclinical AD is amyloid PET. SCD with positive amyloid is the target population for early AD intervention. The investigators aim to extract the diagnostic features from multiple parameter MRI, genetic, blood and clinical data using Max-Relevance and Min-Redundancy (mRMR) algorithm. Then, based on support vector machine (SVM), random forest (RF) and multi-kernel learning (MKL) classification methods, the investigators will construct predicted diagnostic model of preclinical AD."

Trial Locations (1)

100053

RECRUITING

Department of Neurolgy, Xuanwu Hospital of Capital Medical University, Beijing

All Listed Sponsors
collaborator

University of Cologne

OTHER

lead

XuanwuH 2

OTHER